| Stereochemistry | ACHIRAL |
| Molecular Formula | C2O4.Co |
| Molecular Weight | 146.9522 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Co++].[O-]C(=O)C([O-])=O
InChI
InChIKey=MULYSYXKGICWJF-UHFFFAOYSA-L
InChI=1S/C2H2O4.Co/c3-1(4)2(5)6;/h(H,3,4)(H,5,6);/q;+2/p-2
| Molecular Formula | C2O4 |
| Molecular Weight | 88.019 |
| Charge | -2 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Co |
| Molecular Weight | 58.933195 |
| Charge | 2 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
There is no information related to the pharmacological activity of COBALTOUS OXALATE (cobalt oxalate), but is existed a mention about biological activity, where were investigated the role of anions, such as sulfate, nitrate, oxalate and acetate on pharmacological properties of metal (including Co), these complexes have been screened against bacterial species, Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa and results have been reported. In addition is known that cobalt oxalate primarily used as catalysts.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
Patents
|
|
PARENT -> SALT/SOLVATE |
|
||
|
|
PARENT -> SALT/SOLVATE | |||
|
|
PARENT -> SALT/SOLVATE |
Showing 1 to 3 of 3 entries